We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$4.96B
AUM Growth
-$641M
Cap. Flow
-$193M
Cap. Flow %
-3.9%
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$33.6M
2
AMZN icon
Amazon
AMZN
+$32.3M
3
CEB
CEB Inc.
CEB
+$27.7M
4
GILD icon
Gilead Sciences
GILD
+$27.3M
5
MRK icon
Merck
MRK
+$25.2M

Sector Composition

Rank Sector Weight
1 Healthcare 19.16%
2 Financials 16.84%
3 Consumer Discretionary 14.26%
4 Technology 13.32%
5 Industrials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMLP icon
376
Alerian MLP ETF
AMLP
$13.4B
$413K 0.01%
6,613
+1,090
+20% +$79.3K
TRMB icon
377
Trimble
TRMB
$14.3B
$411K 0.01%
25,004
-1,610
-6% -$32.5K
SMG icon
378
ScottsMiracle-Gro
SMG
$3.53B
$405K 0.01%
6,655
-525
-7% -$32.4K
ICE icon
379
Intercontinental Exchange
ICE
$90.5B
$404K 0.01%
8,605
-50
-0.6% -$2.31K
ES icon
380
Eversource Energy
ES
$26.7B
$394K 0.01%
7,792
+28
+0.4% +$1.35K
RJF icon
381
Raymond James Financial
RJF
$33.9B
$385K 0.01%
11,643
SQBK
382
DELISTED
SQUARE 1 FINANCIAL INC COM
SQBK
$385K 0.01%
15,000
PNY
383
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$385K 0.01%
9,600
IYY icon
384
iShares Dow Jones US ETF
IYY
$3.06B
$382K 0.01%
7,926
-284
-3% -$14.5K
CMP icon
385
Compass Minerals
CMP
$1.05B
$381K 0.01%
4,858
-523
-10% -$42.9K
CHSCL
386
CHS Inc Class B Series 4 Preferred Stock
CHSCL
$528M
$371K 0.01%
14,000
VLRS
387
Controladora Vuela Compania de Aviacion
VLRS
$792M
$370K 0.01%
+24,791
New +$341K
BAP icon
388
Credicorp
BAP
$29.6B
$368K 0.01%
3,459
-557
-14% -$67.3K
AWK icon
389
American Water Works
AWK
$27.2B
$367K 0.01%
6,661
-185
-3% -$9.67K
EXC icon
390
Exelon
EXC
$45.3B
$367K 0.01%
17,340
-694
-4% -$15.6K
ABEV icon
391
Ambev
ABEV
$44.4B
$366K 0.01%
74,613
-12,245
-14% -$66.5K
DVA icon
392
DaVita
DVA
$11.4B
$364K 0.01%
5,035
PETX
393
DELISTED
Aratana Therapeutics, Inc.
PETX
$364K 0.01%
43,074
+18,745
+77% +$317K
CDK
394
DELISTED
CDK Global, Inc.
CDK
$360K 0.01%
7,528
+1,294
+21% +$65.7K
ETP
395
DELISTED
Energy Transfer Partners L.p.
ETP
$359K 0.01%
8,741
+215
+3% +$10.4K
VEU icon
396
Vanguard FTSE All-World ex-US ETF
VEU
$70.7B
$356K 0.01%
8,357
+1,820
+28% +$84K
RDY icon
397
Dr. Reddy's Laboratories
RDY
$10.1B
$355K 0.01%
27,805
-11,015
-28% -$137K
PXD
398
DELISTED
Pioneer Natural Resource Co.
PXD
$355K 0.01%
+2,922
New +$364K
QLD icon
399
ProShares Ultra QQQ
QLD
$14.2B
$349K 0.01%
85,760
+38,400
+81% +$176K
GNMK
400
DELISTED
GenMark Diagnostics, Inc
GNMK
$344K 0.01%
43,667
+19,037
+77% +$176K

Similar funds

Geneva Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.

  • Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
  • Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
  • Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
  • Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
  • Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
  • Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
  • Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.

Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.